FDA OKs First Twice-Daily Steroid for Postsurgery Eye Pain

The nanoparticle formulation of loteprednol etabonate ophthalmic suspension (Inveltys, Kala Pharmaceuticals) is dosed two times daily rather than four times daily, with similar efficacy and safety.
FDA Approvals